Annovis Bio holds webinar Jan 28, 2026; no clinical or financial data furnished

Annovis Bio, Inc.

Company conducted a webinar with CEO Maria Maccecchini; no new results or data disclosed in filing.
Exhibit 99 contains only a title slide and standard forward-looking statement, no financial or clinical details.
No guidance, trial updates, or material business developments were provided in the 8-K exhibit.
Filing is procedural Regulation FD disclosure for the webinar event itself, not a substantive update.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.